Brief: Idera Pharmaceuticals Reports Q4 Loss Per Share Of $1.76

Aceragen

12/03/2020 13:44

March 12 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR
2019
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * Q4 LOSS PER SHARE $1.76
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.35 -- REFINITIV IBES
DATA
    * AS OF DECEMBER 31, 2019, CASH, CASH EQUIVALENTS, AND
SHORT-TERM
INVESTMENTS TOTALED $42.8 MILLION
    * IDERA PHARMACEUTICALS - ANTICIPATE CURRENT CASH, CASH
EQUIVALENTS, & SHORT-TERM INVESTMENTS WILL FUND OPERATIONS INTO
FIRST QUARTER OF 2021

Source text for Eikon:  ID:nGNX27VlpR 
Further company coverage:  IDRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))